Stockholders elect four directors at International Stem Cell annual meeting

International Stem Cell CORP

Andrey Semechkin and Russell Kern elected directors by Series D Preferred Stock with 2,457,143 votes each.
Donald A. Wright (9,288,444 for, 30,590 withheld) and Paul V. Maier (9,288,500 for, 30,534 withheld) elected by all shareholders on as-converted basis.
Annual meeting held June 11, 2026; no other proposals were considered.
All director terms run until the 2027 Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

International Stem Cell CORP shareholders approved Election of four directors to hold office until the 2027 Annual Meeting at the 2026-06-11 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-11

Exact text from the filing

Proposal 1: Election of four directors to hold office until the 2027 Annual Meeting: A. Directors elected by holders of Series D Preferred Stock: FOR WITHHELD Andrey Semechkin 2,457,143 0 Russell Kern 2,457,143 0 B. Directors elected by holders of all shares of stock (including shares of preferred stock voting on an as-converted basis): FOR WITHHELD Donald A. Wright 9,288,444 30,590 Paul V. Maier 9,288,500 30,534 Broker Non-Votes: none All of the foregoing candidates were elected.

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

International Stem Cell CORP filing history →

Source: SEC EDGAR

accession 0001683168-26-004786

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.